ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,866.83
-1.65%
S&P 500
5,221.42
-0.02%
Dow Jones
39,431.51
-0.21%
US Dollar vs Yen
156.458
0.14%
Brent Oil
82.935
-0.33%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Amarin Corp PLC (AMRN)

  7. Amarin Corp PLC (AMRN) ニュース

AMRN

Amarin (AMRN)

Amarin Corp PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AMRN
日付受信時刻ニュースソース見出しコード企業名
2024/05/0621 : 00GlobeNewswire Inc.Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:AMRNAmarin Corp PLC
2024/05/0120 : 00GlobeNewswire Inc. Amarin Reports First Quarter 2024 Business Update and Financial ResultsNASDAQ:AMRNAmarin Corp PLC
2024/04/2503 : 00GlobeNewswire Inc.Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular EventNASDAQ:AMRNAmarin Corp PLC
2024/04/2221 : 00GlobeNewswire Inc.Amarin Announces Results of Annual General Meeting of ShareholdersNASDAQ:AMRNAmarin Corp PLC
2024/04/1521 : 00GlobeNewswire Inc.Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024NASDAQ:AMRNAmarin Corp PLC
2024/04/0821 : 00GlobeNewswire Inc.Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24NASDAQ:AMRNAmarin Corp PLC
2024/04/0819 : 30PR Newswire (Canada)New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
2024/04/0704 : 30GlobeNewswire Inc.New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
2024/04/0321 : 00GlobeNewswire Inc.Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeNASDAQ:AMRNAmarin Corp PLC
2024/03/2521 : 00GlobeNewswire Inc.Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & ExpoNASDAQ:AMRNAmarin Corp PLC
2024/03/0507 : 30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AMRNAmarin Corp PLC
2024/03/0422 : 00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AMRNAmarin Corp PLC
2024/02/2921 : 06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMRNAmarin Corp PLC
2024/02/2921 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
2024/02/2921 : 00GlobeNewswire Inc.Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AMRNAmarin Corp PLC
2024/02/1522 : 00GlobeNewswire Inc.Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024NASDAQ:AMRNAmarin Corp PLC
2024/02/1222 : 00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AMRNAmarin Corp PLC
2024/02/1006 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/1006 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/1006 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/2621 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
2024/01/2506 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/2221 : 30GlobeNewswire Inc.Amarin Chairman & CEO Issue Letter to ShareholdersNASDAQ:AMRNAmarin Corp PLC
2024/01/1307 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1307 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1307 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1021 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
 Showing the most relevant articles for your search:NASDAQ:AMRN

最近閲覧した銘柄

NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
NYSE
BAC
Bank of America
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
CCOM
US100
US Tech 100
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有